A 49-year-old grand with advanced bowel cancer has seen her tumours shrink in half after experimental drug treatment.
Terri Hurdman joined a clinical trial for a new drug that targets a specific gene controlling how cancer grows.
The medicine is so new it has not been given a name yet, but medics are impressed by its results.